Ohta E - Search Results

1

I(2020)T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wild-type molecule.

Ohta E, Katayama Y, Kawakami F, Yamamoto M, Tajima K, Maekawa T, Iida N, Hattori S, Obata F. Ohta E, et al. Biochem Biophys Res Commun. 2009 Dec 18;390(3):710-5. doi: 10.1016/j.bbrc.2009.10.034. Epub 2009 Oct 13. Biochem Biophys Res Commun. 2009. PMID: 19833102

2

A new mutation (Thr106Ile) of the GTP cyclohydrolase 1 gene associated with DYT5 dystonia (Segawa disease).

Ohta E, Toyoshima I, Funayama M, Ichinose H, Hasegawa K, Obata F. Ohta E, et al. Mov Disord. 2005 Aug;20(8):1083-4. doi: 10.1002/mds.20490. Mov Disord. 2005. PMID: 15852365 No abstract available.

3

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F. Funayama M, et al. Among authors: ohta e. Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484. Ann Neurol. 2005. PMID: 15880653

4

Novel mutations in the guanosine triphosphate cyclohydrolase 1 gene associated with DYT5 dystonia.

Ohta E, Funayama M, Ichinose H, Toyoshima I, Urano F, Matsuo M, Tomoko N, Yukihiko K, Yoshino S, Yokoyama H, Shimazu H, Maeda K, Hasegawa K, Obata F. Ohta E, et al. Arch Neurol. 2006 Nov;63(11):1605-10. doi: 10.1001/archneur.63.11.1605. Arch Neurol. 2006. PMID: 17101830

5

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.

Ohta E, Hasegawa K, Gasser T, Obata F. Ohta E, et al. Neurosci Lett. 2007 Apr 24;417(1):21-3. doi: 10.1016/j.neulet.2007.02.086. Epub 2007 Mar 16. Neurosci Lett. 2007. PMID: 17395370

6

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis.

Ohta E, Kubo M, Obata F. Ohta E, et al. Biochem Biophys Res Commun. 2010 Jan 1;391(1):242-7. doi: 10.1016/j.bbrc.2009.11.043. Epub 2009 Nov 11. Biochem Biophys Res Commun. 2010. PMID: 19912990

7

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen.

Maekawa T, Kubo M, Yokoyama I, Ohta E, Obata F. Maekawa T, et al. Among authors: ohta e. Biochem Biophys Res Commun. 2010 Feb 12;392(3):431-5. doi: 10.1016/j.bbrc.2010.01.041. Epub 2010 Jan 15. Biochem Biophys Res Commun. 2010. PMID: 20079710

8

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation.

Kubo M, Kamiya Y, Nagashima R, Maekawa T, Eshima K, Azuma S, Ohta E, Obata F. Kubo M, et al. Among authors: ohta e. J Neuroimmunol. 2010 Dec 15;229(1-2):123-8. doi: 10.1016/j.jneuroim.2010.07.021. Epub 2010 Aug 21. J Neuroimmunol. 2010. PMID: 20728949

9

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.

Ohta E, Kawakami F, Kubo M, Obata F. Ohta E, et al. FEBS Lett. 2011 Jul 21;585(14):2165-70. doi: 10.1016/j.febslet.2011.05.044. Epub 2011 Jun 2. FEBS Lett. 2011. PMID: 21658387 Free article.

10

Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.

Kawakami F, Suzuki M, Shimada N, Kagiya G, Ohta E, Tamura K, Maruyama H, Ichikawa T. Kawakami F, et al. Among authors: ohta e. FEBS J. 2011 Dec;278(24):4895-904. doi: 10.1111/j.1742-4658.2011.08389.x. Epub 2011 Oct 31. FEBS J. 2011. PMID: 21985244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters